APA (7th ed.) Citation

S, V., P, V., & V, R. (2026). Advancement of an (in vitro/ex vivo) hybrid model framework to forecast polyviral lung disease outcomes. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 74(5), 438. https://doi.org/10.1177/10815589251382266

Chicago Style (17th ed.) Citation

S, Varalakshmi, Vijayalakshmi P, and Rajendran V. "Advancement of an (in Vitro/ex Vivo) Hybrid Model Framework to Forecast Polyviral Lung Disease Outcomes." Journal of Investigative Medicine : The Official Publication of the American Federation for Clinical Research 74, no. 5 (2026): 438. https://doi.org/10.1177/10815589251382266.

MLA (9th ed.) Citation

S, Varalakshmi, et al. "Advancement of an (in Vitro/ex Vivo) Hybrid Model Framework to Forecast Polyviral Lung Disease Outcomes." Journal of Investigative Medicine : The Official Publication of the American Federation for Clinical Research, vol. 74, no. 5, 2026, p. 438, https://doi.org/10.1177/10815589251382266.